These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15929860)

  • 1. New benefits of statin treatment.
    Boden G
    Curr Diab Rep; 2005 Jun; 5(3):165; discussion 165-6. PubMed ID: 15929860
    [No Abstract]   [Full Text] [Related]  

  • 2. More than a statin.
    Underwood A
    Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505
    [No Abstract]   [Full Text] [Related]  

  • 3. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 4. By the way, doctor... My doctor tells me that because I have diabetes and moderately high "bad" LDL cholesterol, I should be taking a statin. Is there any statin that's better than the rest? And what side effects should I be concerned about?
    Lee TH
    Harv Health Lett; 2001 Aug; 26(10):8. PubMed ID: 11546622
    [No Abstract]   [Full Text] [Related]  

  • 5. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
    Hurley DL; Isley WL
    Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
    [No Abstract]   [Full Text] [Related]  

  • 6. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

  • 7. Should every patient with diabetes receive a statin?
    Dembowski E; Davidson MH
    Pol Arch Med Wewn; 2008; 118(7-8):398-401. PubMed ID: 18714733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statins remain the standard. New methods for lipid lowering therapy].
    Aumiller J
    MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 10. [When statins alone are not enough. Putting a vice grip on cholesterol].
    MMW Fortschr Med; 2002 Jun; 144(23):52-3. PubMed ID: 12119909
    [No Abstract]   [Full Text] [Related]  

  • 11. Zetia (ezetimibe).
    Kloner RA
    Congest Heart Fail; 2003; 9(2):109-10. PubMed ID: 12671344
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recommended LDL value far lower. How does one achieve this goal?].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116
    [No Abstract]   [Full Text] [Related]  

  • 13. Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.
    Sniderman AD; Thanassoulis G
    Evid Based Med; 2013 Apr; 18(2):73-4. PubMed ID: 22893654
    [No Abstract]   [Full Text] [Related]  

  • 14. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol.
    Nichols GA; Philip S; Reynolds K; Granowitz CB; Fazio S
    Diabetes Obes Metab; 2019 Feb; 21(2):366-371. PubMed ID: 30225881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in pharmacotherapy.
    Thompson GR
    Cardiovasc J S Afr; 2004; 15(2):56-8. PubMed ID: 15148538
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
    Frolkis JP; Pearce GL; Sprecher DL
    Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 20. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
    MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.